Personalized peptide protocols — prescribed by US-licensed physicians, custom-compounded by 503A pharmacies, and delivered to your door. Pre-dosed pens or sublingual tablets, depending on what your physician determines is right for you.
No waiting rooms. No referrals. From signup to your first delivery in under 7 days — every step touched by a licensed physician.
Pre-dosed pens, sterile vials, and sublingual strips — all branded Lior, all from 503A-certified US compounding pharmacies. Every protocol prescribed and monitored by your physician.
We compete on rigor, not marketing. Click any row to see the detail. Verified against publicly disclosed practices of typical telehealth peptide vendors.
Peptide therapy is a real medical category with decades of research behind it. We publish plain-English explainers on how it actually works, what the research says, and how Lior fits in.
The biology, the categories, and why peptide therapy isn't the same as a supplement or a hormone. Start here if you're new to the category.
The mechanism, the trial data (STEP 1 and SURMOUNT-1), the difference between mono- and dual-receptor agonists, and what compounded versions are.
Why your prescription is "compounded," who oversees the pharmacy that makes it, and how to tell legitimate compounding apart from grey-market sourcing.
Why Enclomiphene + Kisspeptin + Sermorelin work differently from TRT or estrogen replacement, and when each is clinically appropriate.
A research-grounded look at the recovery peptides Lior prescribes — mechanisms studied, contexts of use, and current regulatory status.
What to look for in a peptide telehealth platform — physician credentials, pharmacy partnerships, off-label disclosure, and red flags to avoid.
Every Lior patient is reviewed by a US-licensed physician who designs the protocol and monitors progress. Lior physicians are independent providers operating through their own professional corporations and licensed in the states we serve.
Our medical team is being onboarded for the soft launch. Named providers, credentials, and state-by-state coverage will appear here as physicians complete onboarding and confirm participation in writing. We don't list physicians who haven't signed on.
Peptide therapy isn't new. It's a recognized category in modern medicine with decades of clinical research, dozens of FDA-approved drugs, and a body of peer-reviewed evidence that's grown faster every year for the last decade. Here's what the published data actually shows.
Projected to grow at ~9% CAGR through 2030. Source: Grand View Research market analysis.
Marketed today across endocrine, metabolic, oncology, and reproductive categories — including GLP-1 agonists (Semaglutide, Tirzepatide, Liraglutide), GHRH analogs (Tesamorelin), GnRH analogs, and dozens more.
Mechanisms, indications, safety profiles, and clinical trial results — across every major peptide class. Search "peptide therapeutics" on PubMed for the live count.
Peptides are short chains of amino acids — the same molecules your body already uses to signal between cells. Unlike small-molecule drugs that block or force a pathway, peptides modulate existing signaling. Think tuner, not switch.
Phase 3 trials of GLP-1 receptor agonists (STEP 1, SURMOUNT-1, published in NEJM) document mean body-weight reductions of ~15–22% over 68–72 weeks. Mechanism: peptide-receptor binding modulates appetite signaling at the brain level. Outcomes vary by patient.
503A pharmacies prepare patient-specific doses pursuant to a valid prescription. This lets your physician titrate to your individual response — different from off-the-shelf retail medications. Compounded medications are not FDA-approved; they are prepared on a patient-specific basis.
Further reading: PubMed — peptide therapeutics · FDA Drug Approval Process · STEP 1 trial — Semaglutide for Weight Loss (NEJM 2021) · SURMOUNT-1 trial — Tirzepatide (NEJM 2022)
The information above is general educational content about the peptide therapeutics category. It is not a representation about outcomes any individual Lior patient will experience. Lior protocols are physician-prescribed for individual patients; outcomes vary. See compounded-medication and off-label disclosures in our footer.
We're onboarding our first cohort of patients. Join the waitlist to reserve your spot — we'll reach out as your slot opens.